-
Abrocitinib
Zita reAPI Indication Innovator Patent Expiry Date (The US) Abrocitinib Atopic Dermatitis Pfizer Kukadzi.11, 2034 -
Agomelatine
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Agomelatine Kuora mwoyo Mumba √ -
Apixaban
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Apixaban VTE Mumba -
Atorvastatin Calcium
Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP Atorvastatin Calcium Hypercholesterolemia Mumba/CEP 29057 √ CEP 2015-034